Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States

18 February 2022 : Original article

Shingo Shimada^1ADEF*, Toshihiro Kitajima^1BCE, Yukiko Suzuki^1BD, Yasutaka Kuno^1BD, Tayseer Shamaa^1BC, Tommy Ivanics

^1BCE, Kelly Collins^1DE, Michael Rizzari^1BD, Atsushi Yoshida^1BD, Marwan Abouljoud^1BD, Dilip Moonka^2BD, Shunji Nagai^1ACE

DOI: 10.12659/AOT.934850

Ann Transplant 2022; 27:e934850

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 9 Cause of 1-year death in patient who underwent liver transplant alone between the eras.

n (%)	Overalln=14 (14.7)	Before the 2017 policyn=8 (20.0)	After the 2017 policyn=6 (10.9)
Graft failure, n (%)	0 (0)	0 (0)	0 (0)
Infection, n (%)	8 (57.1)	6 (75.0)	2 (33.3)
Brain hemorrhage, infarction, n (%)	1 (7.1)	0 (0)	1 (16.7)
Multi organ failure, n (%)	2 (14.3)	2 (25.0)	0 (0)
Others, n (%)	3 (21.4)	0 (0)	3 (50.0)
LTA – liver transplant alone.

Back to the Article